The Cochrane Collaboration is proud to announce our new scientific strategy, focusing on tackling the most pressing global health issues driving inequity. 

“When my husband was faced with a major decision between surgery and radiation for his cancer treatment, we were overwhelmed by the different perspectives from the specialists — each one focusing only on their own treatment. No one put the options side by side. That’s where the patient decision aids made all the difference. We felt empowered, informed, and confident in the choice we made — knowing we had truly considered every option.” — Maureen Smith, caregiver and patient advocate. 

The World Health Organization (WHO) has recently launched new guidance on best practices for clinical trials.

Cochrane is excited to announce The People’s Review, a project designed to empower individuals worldwide to take part in a systematic review. The People’s Review invites the public to learn about systematic reviews by directly participating in the process.

World Evidence-based Heathcare Day is held on 20 October each year. It is a global initiative that raises awareness of the need for better evidence to inform healthcare policy, practice and decision making in order to improve health outcomes globally.

Cochrane’s systematic reviews are playing a key role in informing the World Health Organization’s (WHO) guidelines for managing preterm infants, including respiratory interventions. These reviews, led by Cochrane Sweden and Cochrane Neonatal, are providing the evidence that is directly shaping recommendations on treatments like caffeine therapy to support lung function in preterm babies. 

The dental health benefits of adding fluoride to drinking water may be smaller now than before fluoride toothpaste was widely available, an updated Cochrane review has found. 

A review published in 2015 found a reduction of atrial fibrillation in people undergoing heart surgery if they were given statins before surgery. However, the review was withdrawn in 2016 when questions were raised about some of the included studies.

Cochrane workshop «New tools for developing and assessing the quality of evidence-based clinical guidelines for safety of pharmacotherapy», organized by Cochrane Russia together with Cochrane China, was held as a part of the Second Russian Congress «Safety of pharmacotherapy 360°: Noli Nocere!» at RMANPO on May 23, 2024.Seminar recording 

Russian congress«SAFETY OF PHARMACOTHERAPY 360°: NOLI NOCERE! »Cochrane Russia Workshop: Evidence-Based Clinical Guidelines for the Safety of Pharmacotherapy«SAFETY OF PHARMACOTHERAPY 360°: NOLI NOCERE!» congress registration here23 May 2024 г. 14.45 – 16.20, room 3Moderators: